v3.26.1
SCHEDULE OF BRIAPRO RESTRICTED STOCK UNITS GRANTED (Details) (Parenthetical) - Restricted Stock Units (RSUs) [Member] - USD ($)
 9 Months Ended
Apr. 01, 2026
Sep. 24, 2025
Apr. 30, 2026
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
RSU's, granted [1]     40,000
Number of options granted   $ 376,000  
Director [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
RSU's, granted   40,000  
BriaPro Therapeutics Corp, [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
RSU's, granted [2]     7,189,000
Number of options granted $ 262,399    
Grant-date fair value $ 0.0365    
BriaPro Therapeutics Corp, [Member] | Director [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
RSU's, granted 7,189,000    
[1] On September 24, 2025, the Company granted 40,000 RSUs to directors under the Omnibus Plan. These RSUs vest in full on the earlier of September 23, 2028 or the occurrence of a change of control, resignation, or dismissal without cause. The grant-date fair value of these RSUs was $376,000.
[2] On April 1, 2026, BriaPro granted 7,189,000 RSUs to directors under the Omnibus Plan. These RSUs vest in full on April 1, 2027. The grant-date fair value of these RSUs was $262,399, based on a grant-date fair value of $0.0365 per RSU.